��躰�肽𨯙嚙踝蕭�椬��㮖����𠺪蕭��辷蕭
��躰�頣蕭皛抵�䈑蕭嚙踝蕭膌见�躰�肽𨯙
��躰�肽𨯙嚙踝蕭颲瑁𨯙�𢥫嚙質�嚙踢�𧶏蕭薳��𨯙
��躰釭嚙賢��𨯙嚙賡ㄤ��躰釭嚙賭�對蕭嚙�
��躰釭嚙賢��𨯙嚙踝蕭蒺矋蕭嚙賣���辷蕭
��躰�頣蕭嚙質𨯙��鞱�矋蕭��躰�肽𨯙嚙踢岡芾働嚙�
��躰�頣蕭皛抵�䈑蕭嚙踝蕭嚙賢�磰𨯙嚙踢﹜���躰�肽𨯙��躰�肽𨯙
嚙賭麩��躰�肽𨯙嚙賭�𡑒𨯙��躰�肽𨯙��躰�肽𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踝蕭��躰�頣蕭�迚�𨯙
��躰�肽𨯙嚙踝蕭嚙踢�佅嚙賢�躰�肽𨯙嚙踝蕭�迚�𨯙
��躰�肽𨯙嚙賜�嚙踝蕭臐�鳴蕭�莎蕭撠𩤃蕭臐�航𨯙��躰郭嚙踢岸��𨯙��辷蕭
��躰�肽𨯙��躰�肽𨯙嚙賡做嚙踢╱ｇ蕭暻芸�躰腺�𧊋臐�航𨯙��躰�肽𨯙
嚙踝蕭��嚙質�磰𨯙��躰�肽𨯙嚙賢䐓��躰釭臐�嚙踝蕭嚙踝蕭��辷蕭
��躰釭嚙賢��𨯙嚙踢�鍦�躰�栶�笔�辷蕭
��躰都嚙賢�躰腺嚙賬���躰腺嚙賢��
��躰酗��𥕦�躰郭��嚙賢��𨯙��鮋ㄙ
��躰都嚙賢�躰腺嚙賬���躰�肽𨯙��躰�肽𨯙��辷蕭
��躰都嚙賢�躰腺嚙賬�嚙踝蕭嚙質𨯙��躰�肽𨯙
��躰酗藆�坿���嚙質�𨅯�𡑒��𨯙��辷蕭
��躰酗��𨥈蕭嚙踢�航𨯙嚙踝蕭嚙踝蕭臐��𨯙
嚙踢坎萘���朞𨯙�坾蝞�嚙賢�躰�肽𨯙��辷蕭
��躰閉瘣賢�躰酗嚙踢�航𨯙�����𨯙��辷蕭
嚙踢△�嚙踝蕭嚙質𨯙嚙踝蕭璇寡𨯙��辷蕭
��躰�肽𨯙��躰腺銝滚��𨯙��躰�肽𨯙��躰�肽𨯙
��躰�肽𨯙��𥕦�页蕭���𧒆䕘蕭薴ㄟ��躰腺��舘�舘𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踢�𦴣��躰�肽𨯙��躰�肽𨯙
��躰閉�蕟��躰�肽𨯙��嚙踝蕭�𨯙��琜蕭藃�讛𨯙��辷蕭
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰�肽𨯙��躰�肽𨯙
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰部薴钟��辷蕭
��躰腺嚙賣�坿𨯙��嚙賣Ⅰ�𨯙��躰�肽𨯙��辷蕭
��躰腺嚙賣�坿𨯙��嚙賜�橘蕭嚙質�芷礆嚙�
嚙踝蕭臐号艟洽嚙踝蕭��磰𨯙��躰�肽𨯙��辷蕭
��躰�肽𨯙嚙賢𠘕嚙賢𠹭��㚁蕭銧游�辷蕭
��躰�肽𨯙��𥟇䠋�𨯙��躰�肽𨯙��𥪮�航𨯙
嚙踝蕭�緾嚙賢�躰郭嚙賭�𡑒𨯙嚙踝蕭嚙�
��躰�肽𨯙嚙踢╱Ｚ躀臐��𨯙��躰�肽𨯙��辷蕭
嚙踝蕭艟妟��𥕦�躰郭嚙賭�𤏸𨯙��躰�肽𨯙��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭嚙踝蕭�佞𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭擗�𠯫�𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭憍辷蕭�莎蕭嚙質鷄嚙踝蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜脩腦嚙踢𧒆��辷蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜賂蕭�樹𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰釭蝮�蕭�𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰郭嚙賜�樹𧒆��辷蕭
��躰腺�亙�滩𨯙��躰�頣蕭��𡏭𨯙��躰�肽𨯙�����痹蕭嚙�
��躰�肽𨯙嚙踢𧒆䕘蕭嚙踢孜讛𨯙��躰�肽𨯙��辷蕭
嚙踝蕭���蕭�䁥滩𨯙��琜蕭�迚�𨯙��辷蕭
��躰�肽𨯙��躰郭�𨺗��躰�肽𨯙
��躰�肽𨯙��躰�肽𨯙嚙踝蕭隤抵���嚙賬答�𨯙��躰�肽𨯙
明基材(8215)
月營收
季盈餘
2025/03/01
25.65元 (明基材股價)
2025/03/01
2.89% (年增率)
1,658百萬元 (營收)
明基材(8215) 年度營收走勢圖
明基材(8215)月營收明細
單位：仟元
年/月
營收
月增率
去年同期
年增率
累計營收
年增率
114/03
1,657,788
6.24%
1,611,225
2.89%
4,580,499
-0.27%
114/02
1,560,346
14.53%
1,413,213
10.41%
2,922,710
-1.98%
114/01
1,362,364
-15.58%
1,568,570
-13.15%
1,362,364
-13.15%
113/12
1,613,727
-3.80%
1,214,996
32.82%
18,593,978
8.56%
113/11
1,677,542
2.76%
1,110,981
51.00%
16,980,251
6.71%
113/10
1,632,557
3.38%
1,497,256
9.04%
15,306,557
3.41%
113/09
1,579,238
2.01%
1,584,168
-0.31%
13,673,999
2.78%
113/08
1,548,109
13.44%
1,487,054
4.11%
12,094,762
3.20%
113/07
1,364,720
-20.92%
1,531,080
-10.87%
10,546,653
3.06%
113/06
1,725,730
20.82%
1,601,303
7.77%
9,181,933
5.52%
113/05
1,428,320
-0.46%
1,537,311
-7.09%
7,456,202
5.01%
113/04
1,434,874
-10.95%
1,496,431
-4.11%
6,027,882
8.35%
113/03
1,611,225
14.01%
1,482,096
8.71%
4,593,008
12.94%
113/02
1,413,213
-9.90%
1,335,397
5.83%
2,981,783
15.36%
113/01
1,568,570
29.10%
1,249,451
25.54%
1,568,570
25.54%
112/12
1,214,996
9.36%
1,211,728
0.27%
17,127,523
10.21%
112/11
1,110,981
-25.80%
1,240,384
-10.43%
15,912,528
11.05%
112/10
1,497,256
-5.49%
1,165,914
28.42%
14,801,547
13.09%
112/09
1,584,168
6.53%
1,110,000
42.72%
13,304,291
11.59%
112/08
1,487,054
-2.88%
1,264,800
17.57%
11,720,124
8.39%
112/07
1,531,080
-4.39%
1,271,899
20.38%
10,233,070
7.18%
112/06
1,601,303
4.16%
1,355,750
18.11%
8,701,990
5.15%
112/05
1,537,311
2.73%
1,337,243
14.96%
7,100,687
2.61%
112/04
1,496,431
0.97%
1,418,687
5.48%
5,563,375
-0.35%
112/03
1,482,096
10.99%
1,400,084
5.86%
4,066,944
-2.33%
112/02
1,335,397
6.88%
1,278,239
4.47%
2,584,848
-6.48%
112/01
1,249,451
3.11%
1,485,737
-15.90%
1,249,451
-15.90%
111/12
1,211,728
-2.31%
1,456,910
-16.83%
15,540,465
-5.71%
111/11
1,240,384
6.39%
1,313,074
-5.54%
14,328,738
-4.63%
111/10
1,165,914
5.04%
1,305,444
-10.69%
13,088,353
-4.55%
111/09
1,110,000
-12.24%
1,311,182
-15.34%
11,922,439
-3.90%
111/08
1,264,800
-0.56%
1,381,183
-8.43%
10,812,439
-2.55%
111/07
1,271,899
-6.18%
1,354,490
-6.10%
9,547,639
-1.71%
111/06
1,355,750
1.38%
1,444,421
-6.14%
8,275,740
-1.00%
111/05
1,337,243
-5.74%
1,468,949
-8.97%
6,919,991
0.07%
111/04
1,418,687
1.33%
1,369,750
3.57%
5,582,747
2.51%
111/03
1,400,084
9.53%
1,393,027
0.51%
4,164,060
2.15%
111/02
1,278,239
-13.97%
2,763,976
111/01
1,485,737
1.98%
1,485,737
110/12
1,456,910
10.95%
16,481,686
110/11
1,313,074
0.58%
15,024,776
110/10
1,305,444
-0.44%
13,711,702
110/09
1,311,182
-5.07%
12,406,258
110/08
1,381,183
1.97%
11,095,076
110/07
1,354,490
-6.23%
9,713,893
110/06
1,444,421
-1.67%
8,359,403
110/05
1,468,949
7.24%
6,914,982
110/04
1,369,750
-1.67%
5,446,032
說明：自2013年起上市櫃公司因IFRSs會計準則規範，每月公告的營收必須是合併營收，不再公告非合併營收。2012年(含)前，合併營收是採自願公告。
